SCHEDULE: Saba Capital Boosts Stake in Gabelli Healthcare Trust

Saba Capital Management and affiliates have increased their beneficial ownership in The Gabelli Healthcare & WellnessRx Trust to 13.3%.

Summary

• Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein (collectively, the "Reporting Persons") filed an Amendment No. 3 to Schedule 13D.
• The Reporting Persons collectively beneficially own 2,054,555 Common Shares of The Gabelli Healthcare & WellnessRx Trust.
• This ownership represents 13.3% of the issuer's outstanding common stock.
• The percentage is calculated based on 15,447,824 shares of common stock outstanding as of June 30, 2025, as disclosed in the company's N-CSRS filed September 4, 2025.
• Approximately $19,801,664 was paid to acquire the reported Common Shares.
• Funds for the purchase of Common Shares were derived from investor subscription proceeds, capital appreciation, and margin account borrowings.
• Transactions within the past sixty days prior to October 16, 2025, included several open market purchases of Common Shares.

Sentiment

Score: 7

Explanation: The significant increase in beneficial ownership by Saba Capital, a known activist investor, indicates strong conviction or intent to influence the issuer's strategy, which could be a positive catalyst for shareholders.

Positives

• A significant increase in beneficial ownership by Saba Capital, a known activist investor, may signal strong conviction in the issuer's underlying value or intent to influence strategic direction.
• The substantial investment of approximately $19.8 million demonstrates a material commitment from the Reporting Persons.

Risks

• Positions held in margin accounts are pledged as collateral security for the repayment of debit balances, which may exist from time to time, introducing leverage risk for the Reporting Persons.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance from the issuer. It primarily details an ownership change by an external investor.

Industry Context

Saba Capital Management is recognized as an activist investor, particularly in the closed-end fund space, often seeking to narrow discounts to Net Asset Value (NAV) through various strategies including governance changes or share repurchases. This increased stake in The Gabelli Healthcare & WellnessRx Trust, a closed-end fund focused on healthcare and wellness, aligns with Saba Capital's historical investment patterns and may signal potential future engagement to unlock shareholder value.

Stakeholder Impact

• Shareholders: Potential for increased shareholder value if Saba Capital's activist engagement leads to strategic changes or improved governance.
• Management: May face increased scrutiny or pressure from Saba Capital regarding the fund's performance, discount to NAV, or overall strategy.

Key Dates

Recommendation

The substantial increase in beneficial ownership by Saba Capital, a prominent activist investor, suggests potential for future strategic actions aimed at unlocking shareholder value. Saba's history in closed-end funds often involves advocating for governance changes, share repurchases, or other measures to narrow discounts to NAV. This increased stake could serve as a catalyst for positive changes, making the stock an attractive 'buy' for investors seeking potential activist-driven upside.

Keywords

Gabelli Healthcare & WellnessRx Trust, Saba Capital Management, Boaz R. Weinstein, Schedule 13D, beneficial ownership, closed-end fund, healthcare investment, activist investor